உஓங் திரிே News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from உஓங் திரிே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In உஓங் திரிே Today - Breaking & Trending Today
MATEON'S UPDATE ON C001 - GLOBAL STUDY FOR OT-101 AGAINST COVID-19 yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution 08 March 2021 | News Source credit: Shutterstock Gurugram based Windlas Biotech, in partnership with Mateon Therapeutics in the US, has launched an innovative drug-device therapy PulmoHeal + ARTIHealth as a complete respiratory wellness solution. In a first, the AI-app based platform ARTIHealth™, developed by Mateon Therapeutics will enable patients to monitor the progress of their respiratory function over time by enabling them to upload daily cough and speech recording and receiving feedback on the health of their lungs. The platform is a self-assessment and monitoring tool that provides >90 per cent accurate feedback used for suitable self-care and remote healthcare. This is part of a long-term joint development agreement with IBM Watson Health Research and Mateon. ....
Windlas Biotech, Mateon Therapeutics partner to launch lung therapy solution February 22, 2021 × Developed from Artemisia extract, the active component of PulmoHeal has been known to exhibit multiple pharmacological activities against inflammation, viral infections, and lung repair. Windlas Biotech Pvt. Ltd., an Indian pharmaceutical contract drug development and manufacturing organisation partnered with Mateon Therapeutics, Inc., a US-based oncology company, launched a food supplement, and telemedicine support for respiratory wellness in India. According to the joint official release, in India, around 100 million people suffer from respiratory problems. The key challenges are the lack of cost-effective and lab-free methods for the early diagnosis of diseases. ....
The product, PulmoHeal™ is a broad-spectrum, lung therapy food supplement that is supported by a multi-centre rigorous clinical study and integrated with its own telemedicine AI based platform to offer continuous 360 care for patients in India. Developed from extract of the indigenous plant Artemisia, the active component of PulmoHealTM, Artemisinin, has been known to exhibit multiple pharmacological activity against inflammation, viral infections, and lung repair ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 . Mateon Therapeutics, Inc.January 13, 2021 GMT AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against COVID-19. “These interim results suggest that ARTIVeda is a well-tolerated and effective treatment for COVID-19 that produces a faster recovery time when compared to Standard of Care alone,” said Dr. Vuong Trieu, Chairman and CEO of Mateon. ....